Cost-utility analysis of intravenous immunoglobulin for the treatment of steroid-refractory dermatomyositis in Thailand

• In: Posters: Community Pharmacy: Access to medicines
• At: Bangkok (Thailand) (2014)
• Type: Poster
• Poster code: POS-CPS002
• By: BAMRUNGSAWAD, Naruemon (Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand)
• Co-author(s): Chaiyakunapruk, Nathorn (School of Pharmacy, Monash University Malaysia, Selangor, Malaysia)
  Upakdee, Nilawan (Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Phitsanulok, Thailand)
  Pratoomsoot, Chayanin (Faculty of Public Health, Naresuan University, Phitsanulok, Thailand)
  Sruamsiri, Rosarin (Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Phitsanulok, Thailand)
  Dilokthornsakul, Piyameth (Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Phitsanulok, Thailand)
  
• Abstract:

  Background: Dermatomyositis (DM) is an idiopathic inflammatory disorder characterized by muscle inflammation and skin rash. Intravenous immunoglobulin (IVIG) has demonstrated efficacy in steroid-refractory DM patients. However, IVIG is much more expensive than corticosteroid therapy and DM is an off-label indication for IVIG. Aims: To evaluate the

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login